Annotation Detail for MYO1F
Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| P00044 | Nicotinic acetylcholine receptor signaling pathway |
| Desease Name |
|---|
| height |
| DEVELOPMENTAL |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of MYO1F mRNA | affects expression | 21346803
|
| C014347 |
decitabine |
decitabine results in increased expression of MYO1F mRNA | increases expression | 19194470
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.83 | 7525203 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.53 | 19208741 18320071 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.69 | 19215824 |
| MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.88 | 14694615 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.39 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.11 | 18981723 |
| MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.63 | 15095906 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
2.73 | 21346803 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
6.19 | 19294695 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.80 | 19215824 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
3.51 | 17581917 |
| MESH:D007938 |
Leukemia |
|
decitabine |
3.27 | 19235587 18980019 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.55 | 17236224 18454857 19117987 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.44 | 19387464 17679729 18704418 18460780 18206229 19010910 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
6.53 | 18055864 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
3.76 | 19470736 |
| MESH:D008545 |
Melanoma |
|
decitabine |
2.29 | 16505122 17785578 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.69 | 18172295 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.62 | 19010910 16882708 19157545 18608210 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
2.91 | 19116145 17925555 19470736 |
| MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
4.60 | 14694615 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.76 | 19259094 19331143 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.90 | 19294695 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.49 | 17616702 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
5.01 | 19155313 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.11 | 19037991 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.71 | 17967635 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.86 | 17616700 19087683 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.98 | 17785578 |
Pharmacogenomics Knowledge Base